GOTHENBURG, Sweden, July 17, 2024 /PRNewswire/ -- Second quarter  Sales of SEK 941 (905) million, an increase of 4% in local currencies and 4% in SEK. Sales per region, in local currencies was -5% in APAC, +11% in EMEA and +5% in Americas. Sales growth per business area, in local currencies, was +3% in Consumables, +40% in Technologies and -7% in Genetics. Gross margin increased to 59.9% (55.8). Operating income before depreciation and amortisation (EBITDA) increased to SEK 327 (293) million, giving an EBITDA margin of 34.7% (32.4). Operating cash flow increased to SEK 236 million (211). Net income increased to SEK 143 (106) million, giving earnings per share of SEK 1.06 (0.78). Vitrolife Group ...